{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:47:11Z","timestamp":1791082031289,"version":"4.1.0"},"reference-count":14,"publisher":"Pharmaceutical Society of Japan","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,4,1]]},"DOI":"10.1248\/bpb.b19-00338","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T22:08:56Z","timestamp":1585692536000},"page":"616-618","source":"Crossref","is-referenced-by-count":20,"title":["Reduced Serum Cholesterol and Triglyceride Levels in a Choline-Deficient L-Amino Acid-Defined High-Fat Diet (CDAHFD)-Induced Mouse Model of Non-alcoholic Steatohepatitis (NASH)"],"prefix":"10.1248","volume":"43","author":[{"given":"Daisuke","family":"Yasuda","sequence":"first","affiliation":[{"name":"Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Torii","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumiko","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Hiraoka","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Kume","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. <i>Hepatology<\/i>, <b>52<\/b>, 1836\u20131846 (2010)."},{"key":"2","unstructured":"2) McPherson S, Hardy T, Henderson E, Burt AD, Day CP, Anstee QM. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implication for prognosis and clinical management. <i>J. Hepatol.<\/i>, <b>62<\/b>, 1148\u20131155 (2015)."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Diehl AM. Lessons from animal models of NASH. <i>Hepatol. Res.<\/i>, <b>33<\/b>, 138\u2013144 (2005).","DOI":"10.1016\/j.hepres.2005.09.022"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Takahashi Y, Soejima Y, Fukusato T. Animal models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. <i>World J. Gastroenterol.<\/i>, <b>18<\/b>, 2300\u20132308 (2012).","DOI":"10.3748\/wjg.v18.i19.2300"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Marcolin E, Forgiarini LF, Tieppo J, Dias S, de Freitas LAR, Marroni NP. Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis. <i>Arq. Gastroenterol.<\/i>, <b>48<\/b>, 72\u201379 (2011).","DOI":"10.1590\/S0004-28032011000100015"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Inoue M, Tazuma S, Kanno K, Hyogo H, Igarashi K, Chayama K. Bach 1 gene ablation reduces steatohepatitis in mouse MCD diet model. <i>J. Clin. Biochem. Nutr.<\/i>, <b>48<\/b>, 161\u2013166 (2010).","DOI":"10.3164\/jcbn.09-122GFR"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Denda A, Kitayama W, Kishida H, Murata N, Tamura K, Kusuoka O, Tsutsumi M, Nishikawa F, Kita E, Nakae D, Konishi Y, Kuniyasu H. Expression of inducible nitric oxide (NO) synthase but not prevention by its gene ablation of hepatocarcinogenesis with fibrosis caused by a choline-deficient, L-amino acid-defined diet in rats and mice. <i>Nitric Oxide<\/i>, <b>16<\/b>, 164\u2013176 (2007).","DOI":"10.1016\/j.niox.2006.07.002"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Matsumoto M, Hada N, Sakamaki Y, Uno A, Shiga T, Tanaka C, Ito T, Katsume A, Sudoh M. An improved mouse model that rapidly developes fibrosis in non-alcoholic steatohepatitis. <i>Int. J. Exp. Pathol.<\/i>, <b>94<\/b>, 93\u2013103 (2013).","DOI":"10.1111\/iep.12008"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Ikawa-Yoshida A, Matsuo S, Kato A, Ohmori Y, Higashida A, Kaneko E, Matsumoto M. Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high fat diet. <i>Int. J. Exp. Pathol.<\/i>, <b>98<\/b>, 221\u2013233 (2017).","DOI":"10.1111\/iep.12240"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Goulooze SC, Cohen AF, Rissmann R. Lomitapide. <i>Br. J. Clin. Pharmacol.<\/i>, <b>80<\/b>, 179\u2013181 (2015).","DOI":"10.1111\/bcp.12612"},{"key":"11","unstructured":"11) Gambino R, Cassader M, Pagano G, Durazzo M, Musso G. Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH? <i>Hepatology<\/i>, <b>45<\/b>, 1097\u20131107 (2007)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Koonen DP, Jacobs RL, Febbraio M, Young ME, Soltys CL, Ong H, Vance DE, Dyck JR. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. <i>Diabetes<\/i>, <b>56<\/b>, 2863\u20132871 (2007).","DOI":"10.2337\/db07-0907"},{"key":"13","unstructured":"13) Martius G, Alwahsh SM, Rave-Fr\u00e4nk M, Hess CF, Christiansen H, Ramadori G, Malik IA. Hepatic fat accumulation and regulation of FAT\/CD36: an effect of hepatic irradiation. <i>Int. J. Clin. Exp. Pathol.<\/i>, <b>7<\/b>, 5379\u20135392 (2014)."},{"key":"14","unstructured":"14) Sahai A, Malladi P, Pan X, Paul R, Melin-Aldana H, Green RM, Whitington PF. Obese and diabetic db\/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. <i>Am. J. Physiol. Gastrointest. Liver Physiol<\/i>, <b>287<\/b>, G1035\u2013G1043 (2004)."}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/4\/43_b19-00338\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T03:22:17Z","timestamp":1585970537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/4\/43_b19-00338\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-00338","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,1]]}}}